Core Viewpoint - The legal opinion letter confirms that Hubei Junyao Health Beverage Co., Ltd.'s differentiated dividend distribution plan for 2024 is compliant with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [1][5]. Group 1: Differentiated Dividend Application - The company plans to distribute cash dividends of 0.80 yuan per 10 shares (including tax), totaling 46,865,920 yuan (including tax) to shareholders, excluding shares repurchased [3][4]. - The company has completed the repurchase of 14,660,000 shares, which will not participate in the profit distribution [4]. Group 2: Calculation Basis for Differentiated Dividend - The total share capital of the company is 600,484,000 shares, with 585,824,000 shares participating in the distribution after excluding repurchased shares [4]. - The reference price for ex-dividend is calculated as 7.61 yuan per share based on the closing price of 7.69 yuan per share before the dividend distribution [4][5]. Group 3: Compliance and Impact - The impact of the differentiated dividend on the ex-dividend reference price is less than 1%, indicating minimal effect on the stock price due to the repurchased shares not participating in the dividend [5]. - The legal opinion concludes that the differentiated dividend distribution adheres to the Company Law, Securities Law, and other relevant regulations, ensuring the protection of shareholder interests [5].

证券代码：605388 证券简称：均瑶健康 公告编号：2025-035 湖北均瑶大健康饮品股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 每股分配比例 A 股每股现金红利0.08元 ? 相关日期 | 股份类别 | 股权登记日 | | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/19 | － | 2025/6/20 | 2025/6/20 | | ? 差异化分红送转： 是 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025 年 5 月 23 日的2024年年度股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 （1）截至本公告披露日，公司总股本 600,484,000 股，扣除回购专户的股份数 14,660,000 股，本次实际参与分配的 ...

国浩律师（上海）事务所 关 于 湖北均瑶大健康饮品股份有限公司 差异化分红事项 之 专项法律意见书 上海市静安区山西北路 99 号苏河湾中心 MT 25-28 层 邮编：200085 25-28/F, Suhe Centre, 99 North Shanxi Road, Jing'an District, Shanghai, China 国浩律师（上海）事务所 专项法律意见书 专项法律意见书 电话/Tel: +86 21 52341668 传真/Fax: +86 21 52341670 国浩律师（上海）事务所 网址/Website: http://www.grandall.com.cn 关于湖北均瑶大健康饮品股份有限公司 2025 年 6 月 差异化分红事项之 致湖北均瑶大健康饮品股份有限公司： 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民 共和国证券法》（以下简称"《证券法》"）、《上市公司股份回购规则》（以 下简称"《回购规则》"）、《上海证券交易所上市公司自律监管指引第 7 号— —回购股份》（以下简称"《监管指引第 7 号》"）、《上海证券交易所股票上 市规则》（以下简称"《上市 ...

证券代码：605388 证券简称：均瑶健康 公告编号：2025-035 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 湖北均瑶大健康饮品股份有限公司 2024年年度权益分派实施公告 A 股每股现金红利0.08元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/19 | － | 2025/6/20 | 2025/6/20 | 差异化分红送转： 是 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025 年 5 月 23 日的2024年年度股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 差异化分红送转方案： （1）截至本公告披露日，公司总股本 600,484,000 股，扣除回购专户的股份数 14,660,0 ...

Core Viewpoint - The article discusses the recent positive developments in the China-US trade negotiations, highlighting the agreement framework reached between the two countries, which aims to resolve trade tensions and address export restrictions on rare earth minerals and magnets [1]. Group 1: Trade Negotiations - Chinese and US teams have reached a preliminary agreement framework after two days of negotiations, which is expected to be approved by President Trump soon [1]. - The framework adds substantial content to the previously stalled agreement on reducing retaliatory tariffs due to China's export restrictions on key minerals [1]. - The negotiations are characterized as candid, in-depth, and constructive, with both sides exchanging views on trade issues of mutual concern [1][2]. Group 2: Market Reactions - Following the positive news from the trade talks, the A-share market rebounded, with the Shanghai Composite Index rising by 0.52% to surpass 3400 points, despite a decrease in trading volume [2][4]. - The rare earth permanent magnet sector saw significant gains, with several stocks hitting the daily limit up, indicating strong market sentiment [5]. Group 3: Industry Developments - Jinli Permanent Magnet announced it has obtained export licenses for the US, Europe, and Southeast Asia, reflecting the potential for increased international trade in the sector [3]. - The automotive parts sector also experienced notable gains, with several companies committing to shorten payment terms to suppliers, indicating a shift in industry dynamics [6]. Group 4: Financial Insights - The article provides insights into the performance of various indices, noting that over 1700 index funds exist, with the highest dividend yield index being the Hong Kong Stock Connect Mainland Financial Index at 9.37% [7][8]. - A total of 48 indices were identified that meet the criteria of having a fund size of at least 2 billion and a dividend yield above 3%, with 16 indices yielding over 6% [9]. Group 5: Capital Flow - The net inflow of capital into the market was reported at 253.86 billion, with the non-bank financial sector seeing the largest inflow [15]. - Specific stocks such as Jianghuai Automobile and Ningde Times attracted significant attention from investors, indicating strong market interest in these companies [15][18].

证券代码：605388 证券简称：均瑶健康 公告编号：2025-034 湖北均瑶大健康饮品股份有限公司 关于召开 2025 年第一季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 6 月 17 日（星期二）上午 10:00-11:00 会议召开方式：网络文字互动 投资者可于 6 月 16 日（星期一）16:00 前登录上证路演中心网站首页点 击"提问预征集"栏目或通过公司邮箱 juneyaodairy@juneyao.com 进行提问。公 司将在说明会上对投资者普遍关注的问题进行回答。 湖北均瑶大健康饮品股份有限公司（以下简称"公司"）已于 2025 年 4 月 30 日发布《公司 2025 年第一季度报告》，为便于广大投资者更全面深入地了解 公司 2025 年第一季度经营成果、财务状况，公司计划于 2025 年 6 月 17 日上午 10:00-11:00 举行 2025 年第一季度业绩说明会，就投资者关心的问题进行交流， 在信息披露允许的范围内就投资者普遍关注 ...

Core Viewpoint - Junyao Health, known as the "first stock of lactic acid bacteria drinks," received a warning letter for failing to timely disclose its performance loss announcement, marking its first loss since going public in 2020 [2][5][10]. Financial Performance - In 2024, Junyao Health reported revenue of 1.458 billion yuan, a year-on-year decline of 10.77%, and a net profit loss of 29.12 million yuan, a year-on-year drop of 150.57% [7][10]. - The loss was primarily attributed to impairment provisions for goodwill (36.43 million yuan), inventory write-downs (12.76 million yuan), and credit impairment losses (36.60 million yuan) [8]. Stock Market Reaction - Despite the poor financial performance, Junyao Health's stock price surged, closing at 12.05 yuan per share on the first trading day after receiving the warning letter, marking a 10.05% increase and a new high for the year [2][13]. - Analysts suggest that the regulatory penalty has removed uncertainty, contributing to the stock's recovery, although there may be emotional or artificial factors influencing the price movements [6][13]. Executive Actions - During the stock price surge, several executives, including directors and supervisors, engaged in concentrated share sell-offs, totaling 383,400 shares and approximately 3.5373 million yuan in cash [4][15]. - The shareholding structure shows significant pledging, with the largest shareholder, Junyao Group, pledging about 151 million shares, accounting for 76.69% of its holdings and 25.11% of the total share capital [19][20].

证券代码：605388 证券简称：均瑶健康 公告编号：2025-034 湖北均瑶大健康饮品股份有限公司 关于召开 2025 年第一季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 6 月 17 日（星期二）上午 10:00-11:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http://roadshow.sseinfo.com） 会议召开方式：网络文字互动 投资者可于 6 月 16 日（星期一）16:00 前登录上证路演中心网站首页点 击"提问预征集"栏目或通过公司邮箱 juneyaodairy@juneyao.com 进行提问。公 司将在说明会上对投资者普遍关注的问题进行回答。 湖北均瑶大健康饮品股份有限公司（以下简称"公司"）已于 2025 年 4 月 30 日发布《公司 2025 年第一季度报告》，为便于广大投资者更全面深入地了解 公司 2025 年第一季度经营成果、财务状况，公司计划于 2025 年 ...

Core Viewpoint - Hubei Junyao Health Beverage Co., Ltd. has been issued a warning letter by the Hubei Securities Regulatory Bureau for failing to disclose its 2024 performance forecast as required by regulations [1][5]. Group 1: Regulatory Actions - The company, along with its executives Wang Junhao, Yu Wei, Cui Peng, and Guo Qin, has been held primarily responsible for the violation of the Information Disclosure Management Measures for Listed Companies [5]. - The warning letter will be recorded in the securities and futures market integrity archives [5]. Group 2: Company Performance - In 2024, the company reported a net profit attributable to shareholders of -29.1164 million yuan, a decline of 150.57% year-on-year [6]. - The company's operating revenue for 2024 was 1.458 billion yuan, a decrease of 10.77% compared to the previous year [6]. - In the first quarter of the current year, the company achieved an operating revenue of 401 million yuan, a year-on-year increase of 1.41%, but the net profit attributable to shareholders decreased by 58.29% [6].

湖北均瑶大健康饮品股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任 重要内容提示： 证券代码：605388 证券简称：均瑶健康 公告编号：2025-033 湖北均瑶大健康饮品股份有限公司（以下简称"公司"）股票于 2025 年 6 月 5 日、6 月 6 日、6 月 9 日连续 3 个交易日内收盘价格涨幅偏离值累计超过 20%。根据《上海证券交易所交易规则》的有关规定，属于股票交易异常波动情 形。 经公司自查及向公司控股股东、实际控制人发函核实、确认，截至本公 告披露日，除公司已披露事项外，不存在其它应披露而未披露的重大事项。 请广大投资者理性投资，注意股票二级市场的交易风险。 一、股票交易异常波动的具体情况 公司股票于 2025 年 6 月 5 日、6 月 6 日、6 月 9 日连续 3 个交易日内收盘 价格涨幅偏离值累计超过 20%。根据《上海证券交易所交易规则》的有关规定， 属于股票交易异常波动情形。 二、公司关注并核实的相关情况 （一）生产经营情况 1 经公司自查，公司目前生产经营活动正 ...